Position in ALKS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15,895,416
+$3,606,740 QoQ
Shares Held
449,531
+2.4% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 42.488059777857366.ToString("F0")%
Shared 0.ToString("F0")%
None 57.511940222142634.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
This page
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,895,416 | 449,531 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,288,676 | 439,195 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,215,110 | 473,837 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,528,438 | 472,857 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,030,604 | 455,197 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $13,365,174 | 464,714 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $12,960,237 | 463,031 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,985,243 | 497,313 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $13,253,228 | 489,591 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $13,479,920 | 485,938 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,670,189 | 238,136 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,325,389 | 234,038 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,463,544 | 229,285 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,958,606 | 228,037 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,830,403 | 216,319 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,974,771 | 200,563 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,541,000 | 172,596 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,804,777 | 163,576 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,108,522 | 165,646 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,987,883 | 162,638 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,059,242 | 163,771 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,428,926 | 171,876 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $3,289,393 | 169,469 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,310,372 | 160,220 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||